The p53 tumor suppressor protein induces apoptosis in response to genotoxic and environmental stresses. Recent studies have revealed the existence of a transcriptionindependent mitochondrial p53 apoptotic pathway; however, the mechanism that regulates its translocation to the mitochondria has been unknown. In this study, we show that the tumor suppressor Tid1 forms a complex with p53 under hypoxic conditions that directs p53 translocation to the mitochondria and the subsequent initiation of the mitochondrial apoptosis pathway. Loss of Tid1 expression abrogated p53 translocation to the mitochondria and inhibited apoptosis, whereas the over-expression of Tid1 promoted p53 mitochondrial localization and apoptosis. Tid1's mitochondrial signal sequence and DnaJ domain were both required for the movement of the p53-Tid1 complex from the cytosol to the mitochondria. When Tid is over-expressed in cancer cell lines expressing mutant p53 isoforms defective in transcriptional activity, mitochondrial localization and pro-apoptotic activities of the mutant p53 proteins was restored. Our results establish Tid1 as a novel regulator of p53-mediated apoptosis, and suggest that therapies designed to enhance Tid1's function in promoting mitochondrial localization of p53 and apoptosis could be an effective therapy in many cancers.
The p53 tumor suppressor protein induces apoptosis in response to genotoxic and environmental stresses. Recent studies have revealed the existence of a transcriptionindependent mitochondrial p53 apoptotic pathway; however, the mechanism that regulates its translocation to the mitochondria has been unknown. In this study, we show that the tumor suppressor Tid1 forms a complex with p53 under hypoxic conditions that directs p53 translocation to the mitochondria and the subsequent initiation of the mitochondrial apoptosis pathway. Loss of Tid1 expression abrogated p53 translocation to the mitochondria and inhibited apoptosis, whereas the over-expression of Tid1 promoted p53 mitochondrial localization and apoptosis. Tid1's mitochondrial signal sequence and DnaJ domain were both required for the movement of the p53-Tid1 complex from the cytosol to the mitochondria. When Tid is over-expressed in cancer cell lines expressing mutant p53 isoforms defective in transcriptional activity, mitochondrial localization and pro-apoptotic activities of the mutant p53 proteins was restored. Our results establish Tid1 as a novel regulator of p53-mediated apoptosis, and suggest that therapies designed to enhance Tid1's function in promoting mitochondrial localization of p53 and apoptosis could be an effective therapy in many cancers.
Introduction
Apoptosis is an intrinsic cellular response to specific environmental stresses that occurs through both p53-dependent and p53-independent pathways (Vogelstein et al., 2000; Fridman and Lowe, 2003) . Certain stress stimuli, including hypoxia, DNA damage and oncogene deregulation, cause cells to activate the p53-mediated cell death pathway. These stresses induce stabilization of p53 protein levels by causing p53 to dissociate from MDM2, which normally targets its degradation (Haupt et al., 1997; Lukashchuk and Vousden, 2007) . This leads to rapid elevation of cellular p53 levels and subsequent activation of apoptotic programs. Although much of the p53 protein remains in the nucleus in which it modulates transcription, a significant amount of p53 also translocates to the mitochondria, in which it directly initiates apoptosis, independent of its transcriptional activity (Mihara et al., 2003) . For example, mutant p53 that lacks the capacity to bind DNA still retains the ability to induce apoptosis (Haupt et al., 1995; Pietsch et al., 2008) , and transfection of p53-null cells with mitochondrially targeted p53 proteins has been shown to induce apoptosis (Mihara et al., 2003) . Of two common polymorphic variants of human p53, Arg72 and Pro72, the variant with greater apoptotic potential, Arg72, also has an enhanced ability to localize to the mitochondria (Dumont et al., 2003) . However, the transport and regulatory mechanisms that direct mitochondrial translocation of p53 and initiate this important p53 cell death program are still poorly understood. Recently, Moll's group showed that MDM2-mediated monoubiquitylation of p53 during cellular stress promotes the shuttling of p53 to the mitochondria; (Marchenko et al., 2007) however, MDM2 itself does not act as a shuttler. The identity of the protein(s) that act as shuttlers during stress-induced p53 mitochondrial translocation is currently unknown.
When localized to the mitochondria, p53 modulates the activities of anti-apoptotic (Bcl-x L and Bcl-2) and pro-apoptotic (BAK) members of the Bcl-2 family, which regulate the integrity of the mitochondrial membrane (Mihara et al., 2003; Chipuk et al., 2004; Leu et al., 2004; Perfettini et al., 2004) . p53 interactions with Bcl-x L and Bcl-2 result in the loss of sequestration of the pro-apoptotic factor, BAX, and release of cytochrome c into the cytoplasm (Mihara et al., 2003; Chipuk et al., 2004) . p53 also induces mitochondrialmediated apoptosis through its interaction with BAK, leading to oligomerization of BAK and cytochrome c release . Mitochondrial localization of p53 and induction of this transcription-independent apoptotic response may be an initial rapid response of the cell to stress stimuli, which is followed by the induction of slower apoptotic and growth inhibitory pathways that are dependent on transcriptional activation of p53 target genes in the nucleus (Erster et al., 2004) . The molecular mechanisms regulating the intracellular trafficking of p53 between the cytosol, the nucleus and the mitochondria remain unclear.
Chaperone proteins are suggested to stabilize and assist in the transport of p53 to the mitochondria (King et al., 2001) . Tid1, also known as mitochondrial Hsp40 (mtHsp40), is the mammalian homolog of the Drosophila tumor suppressor Tid56, and it contains a conserved DnaJ domain through which it interacts with the Hsp70 family of chaperone proteins . As it has an amino-terminal mitochondrial signal sequence, Tid1 resides mainly in the mitochondrial matrix (Lu et al., 2006) . Before it transports to the mitochondria, Tid1 is retained transiently in the cytosol, thus allowing the interaction of Tid1 with numerous cytosolic proteins (Lu et al., 2006) . These properties suggest that Tid1 could have a role in the trafficking of proteins between these two cellular compartments. We hypothesized that Tid1 could be an important regulatory factor in p53 trafficking, particularly with respect to mitochondrial translocation of p53. In this study, we show that Tid1 interacts with p53 to form a complex in response to hypoxic stress that is responsible for guiding p53 to the mitochondria, in which p53 initiates the mitochondrial apoptosis pathway. Tid1 over-expression in cancer cells expressing p53 mutants with reduced pro-apoptotic function restored mitochondrial localization of mutant p53 isoforms and increased apoptosis levels even in the absence of hypoxic stress. Our results show a novel role for Tid1 in p53-mediated apoptosis.
Results
Hypoxia induces apoptosis and p53 translocation to the mitochondria in which it interacts with Tid1 To determine whether p53 and Tid1 interact in the mitochondria under conditions of cellular stress, we subjected MCF-7 human breast cancer cells, which express wild-type p53, to hypoxic stress and assessed levels of apoptosis and localization of the proteins. The cells were treated with desferroxamine mesylote (DFX), which is an iron chelator that mimics hypoxia by enhancing the accumulation of hypoxia-inducible factor 1-a and stimulating the transcription of hypoxia-associating genes (Kim et al., 2007) . DFX has also been shown to upregulate p53 and to induce rapid p53 translocation to the mitochondria (Sansome et al., 2001) . Hypoxia is a key factor influencing cancer cell survival within the tumor microenvironment (Anderson et al., 2006) and hypoxic conditions can also physiologically induce the stabilization of p53 through post-translational mechanisms dependent on hypoxia-inducible factor 1-a (Hammond and Giaccia, 2005) .
Cell viability, as determined through WST-1 colorimetric assays that measures relative metabolic activity of cell populations through reduction of a formazan salt to a colored product, was negatively affected after MCF-7 cells were exposed to DFX (Figure 1a, left) . Further investigation using an in situ TdT-mediated dUTP nick end labeling apoptosis assay and fluorescence-activated cell sorting cell cycle analysis showed that reduced cell viability after DFX treatments was the result of apoptosis ( Figure 1a , middle and right, respectively). Comparable levels of apoptosis were observed after exposure to different genotoxic and hypoxia stress stimuli (Supplementary Figure S1 ). In the absence of DFX treatment, co-localization of p53 and Tid1 was rarely visualized because of low basal levels of p53 in MCF-7 cells ( Figure 1b, upper) ; however, when cells were treated with DFX, p53 protein levels were dramatically increased (Figure 1c) , and p53 co-localized with both Tid1 and Mitotracker, indicating localization of both proteins to the mitochondria (Figure 1b, lower) . Similar results were also observed in U87 glioma cell line (Figure 6b ). Co-localization of p53 and Tid1 were observed as early as 30 min after DFX treatment (Supplementary Figure S2 ) and exposure to different genotoxic and hypoxia stresses (Supplementary Figure  S3) . In contrast to the effect on p53 protein levels, immunoblotting of cell lysates showed that DFX treatments had no effect on the protein levels of Tid1 and mtHsp70 (Figure 1c) .
To assess whether co-localization of p53 and Tid1 reflects a physical protein interaction, MCF-7 cells were subjected to hypoxic stress by DFX treatments and p53 and Tid1 were immunoprecipitated from separate aliquots of the cell lysates (Figure 1d ). Consistent with co-localization data (Figure 1a ), Tid1 reciprocally coimmunoprecipitated with p53 in the absence or presence of DFX, confirming the presence of a physical interaction between Tid1 and p53 ( Figure 1d ). We further examined whether Tid1 associated with p53 in the Figure 1 Hypoxic stress induces apoptosis and p53 translocation to the mitochondria, in which it interacts with Tid1. MCF-7 cells expressing wild-type p53 were incubated in the presence or absence of 125 mM desferroxamine (DFX) for 6 h. (a) Viability was analysed by WST-1 assays (left), cells were co-stained with TO-PRO iodide and an in situ TdT-mediated dUTP nick end labeling (TUNEL) assay to detect apoptotic cells (middle), and cell cycle was analysed by fluorescence-activated cell sorting (FACS) (right). Graphs represent mean ± s.e.m. (b) Cells labeled with Mitotracker (green), for mitochondrial staining, anti-Tid1 antibody (red) and anti-p53 antibody (blue), were visualized by confocal microscopy. (c) Immunobloting analysis of p53, Tid1 and mitochondrial Hsp70 (mtHsp70) in cell lysates. (d) Cell lysates (500 mg) from MCF-7 cells were immunoprecipitated using 2 mg of anti-p53, anti-Tid1 or control IgG antibody (*) and analysed by immunoblotting for p53 and Tid1. (e) Immunoblotting analysis of p53 and Tid1 of subcellular fractions of cell lysates obtained using the Qproteome Cell Compartment Kit (w, whole cell lysates; n, nucleus; c, cytoplasm; m, mitochondria, Qiagen, Valencia, CA, USA). The purity of each cell fraction was monitored by immunoblotting analysis for nuclear (Lamin A), cytoplasmic (b-tubulin), and mitochondrial (mtHsp70) markers. To compare protein expression levels within each cell fraction, the same volume (20 ml) of fractionated cell lysates was loaded in each well. Subcelluar fractions were further analysed using immunoprecipitation and immunoblotting analysis for Tid1 (lower) as described above (* immunoprecipitations with control IgG).
p53 subcellular localization and apoptosis BY Ahn et al cytoplasm or in the mitochondria using subcellular fractionation (Figure 1e ). Untreated and DFX-treated MCF-7 cells were separated into cytoplasmic, nuclear and mitochondrial fractions, and the subcellular distribution of p53 and Tid1 was analysed by immunoblotting using cytoplasmic (tubulin), mitochondrial (mtHsp70) and nuclear (Lamin A) markers to monitor purity of fractions. After DFX treatments, p53 levels increased with predominant levels in mitochondrial fractions, although it was also found in the cytoplasm and nucleus at lower levels (upper). Similarly, in DFXtreated cells, most Tid1 was found in the mitochondria, as in untreated cells, although lower amounts of Tid1 protein were detected in the cytosolic fractions (second row). The Tid1 gene encodes two splicing variants: a long (Tid1 L ) and a short (Tid1s) form (Supplementary Figure S4) . The two lower molecular weight bands are attributable to the processed Tid1 L and Tid1 S isoforms (Tid1 L -P and Tid1 S -P), whereas the two higher molecular weight bands represent the full-length, unprocessed precursor forms (Tid1 L -UP and Tid1 S -UP) (Figure 3b, upper) . Immunoprecipitation of p53 from the different cellular fractions revealed that Tid1 formed a complex with p53 in both the cytosol and mitochondria (Figure 1e , lower). Collectively, these results show that hypoxic stress in human cancer cells induces apoptosis associated with p53 and Tid1 co-localization and interaction at the mitochondria.
Tid1 regulates p53 translocation to the mitochondria in response to hypoxic stress To determine whether or not Tid1 was required to modulate p53 subcellular localization and apoptosis, we used a Tid1 short hairpin RNA adenoviral construct, Ad-shTid1, to suppress the expression of endogenous Tid1 and examined the effects of Tid1 knockdown on p53 subcellular localization and apoptosis of MCF-7 cells in response to DFX treatment-induced hypoxic stress. Infection with Ad-shTid1 resulted in over 90% suppression of Tid1 expression ( Figure 2a ). The loss of Tid1 inhibited mitochondrial localization of p53 and led instead to an accumulation of p53 in the nucleus (Figure 2b , lower). The loss of p53 mitochondrial localization in response to stress when Tid1 expression was suppressed was also confirmed in response to other genotoxic stresses, including ultraviolet (40 J/m 2 ) and Camp (5 mM) for 6 h (Supplementary Figure S5) . Cells in which Tid1 was knocked down had significantly lower levels of apoptosis (B10%), compared with that observed in cells infected with the Ad-scramble control (B28%) (Figure 2c ), despite the increased nuclear localization of p53 in hypoxic Tid1 knockdown cells (Figure 2b , lower), suggesting that transcription-dependent p53-mediated apoptosis (Vogelstein et al., 2000; Fridman and Lowe, 2003) was not enhanced in the knockdown cells. Tid1 suppression also reduced levels of apoptosis induced by other genotoxic stresses, including ultraviolet (40 J/m 2 ) and Camp (5 mM) for 6 h, whereas it had no effect on apoptosis levels induced by ER stress through TG (2 mM) treatment (Puthalakath et al., 2007) or by p53-independent death stimuli, including ST (0.5 mM) or SB (1 mM) treatments (Chopin et al., 2002; Mooney et al., 2002) (Supplementary Figure  S6) . In addition, loss of Tid1 was found to alter mitochondrial levels of Bcl-x L and PUMA after hypoxic and genotoxic stress stimuli, whereas it did not alter subcellular localization of Bax and Bid after hypoxic or genotoxic stresses (Supplementary Figure S7) . Suppression of Tid1 expression in cells subjected to hypoxic stress does not cause G1 or G2M cell cycle arrest (Supplementary Figure S8A) , nor is there detectable differences in p53 transcriptional activity as measured by a p53 luciferase reporter assay (Supplementary Figure S8B) . These results show that suppression of Tid1 expression inhibits hypoxia stress-induced p53 mitochondrial localization and apoptosis in human breast cancer cells, and suggest that Tid1 has a direct role in mediating p53's translocation to mitochondria. p53 subcellular localization and apoptosis BY Ahn et al Cytosolic retention of p53 by Tid1 domain deletion mutants inhibits hypoxia stress-induced mitochondrial localization of p53 and apoptosis As Tid1 has a predicted mitochondrial processing sequence (LRP-GV) in the amino-terminal (NT) domain that results in cleavage at amino acid 66 on entry into the mitochondria (Lu et al., 2006) , loss of the NT domain would be expected to inhibit mitochondrial translocation and apoptosis through the mitochondrial pathway. In addition, the conserved DnaJ domain of Tid1 is important for its co-chaperone function , and complexes with both mtHsp70 and p53 (data not shown). Thus, we predicted that the DnaJ domain of Tid1 would be required for p53 binding and subsequent translocation to the mitochondria during hypoxia and that deletion of the DnaJ domain would inhibit this pathway.
To further assess the functional role of Tid1 in hypoxia-induced p53 mitochondrial localization and apoptosis, we over-expressed Tid1 L , Tid1 S or Tid1 S NT domain deletion (Tid1 s DNT) or DnaJ domain histidine to glutamine substituted (Tid1 S HQ) mutants ( Figure 3a ) in MCF-7 cells using adenoviral infections followed by treatments with DFX, and examined p53 localization and apoptosis. The presence of p53 and wild-type or mutant Tid1 in each cellular compartment was analysed by immunoblotting ( Figure 3b ) and immunofluorescence ( Figure 3c ). As the NT domain of Tid1 is cleaved through processing in the mitochondria (Supplementary Figure S4) (Lu et al., 2006) , Tid1 S DNT has a similar band size to endogenous Tid1 S -P (Figure 3b, upper right) . Similarly, unprocessed and processed forms of Tid1 S HQ have similar band sizes to endogenous Tid1 S -UP and Tid1 S -P, although the majority of Tid1 S HQ was found in cytosolic fractions (upper right). The amount of p53 present in mitochondrial fractions was increased in cells over-expressing either Tid1 L or Tid1 S and decreased in cells overexpressing either the NT domain deletion mutant (Tid1 S DNT) or the DnaJ domain mutant (Tid1 S HQ) (Figure 3b, upper) . As expected, p53 localization to mitochondria was decreased in cells expressing either Tid1 S DNT or Tid1 S HQ (Figure 3c , fourth and fifth rows). In contrast, mitochondrial localization of p53 was observed in control cells (first row) and to a greater extent in cells over-expressing wild-type Tid1 L or Tid1 S (second and third rows). The amount of p53 that co-immunoprecipitated with Tid1 was relatively higher in the cytosol than in the mitochondria in cells expressing Tid1 S DNT or Tid1 S HQ when compared with control cells or cells over-expressing wild-type Tid1 S (Figure 3b, bottom) . In accordance with these results, p53 had reduced co-localization with Mitotracker in the cells expressing Tid1 S DNT or Tid1 S HQ (Figure 3c , fourth and fifth columns) compared with the cells overexpressing wildtype Tid1 L or Tid1 S (second and third columns).
The observed cytosolic retention of p53 and Tid1 S domain deletion mutants was associated with a significant decrease in observed levels of hypoxia stress-induced apoptosis (Figure 3d ) whereas cells over-expressing either Tid1 S or Tid1 L consistently showed higher levels of apoptosis (B55%) than that observed in control cells (B25%). To identify the specific apoptotic pathways induced by hypoxia in cells over-expressing Tid1, several different apoptotic inhibitors, including BAX-inhibitor peptide, caspase-9 inhibitor (Z-LEHD-FMK) and caspase-8 inhibitor (Z-IETD-FMK) were used (Gomez et al., 2007) (Figure 4a ). BAX-inhibitor peptide is designed based on the Bax-binding domain of Ku70 and this interaction suppresses Bax-mediated apoptosis (Gomez et al., 2007) . BAX-inhibitor peptide alone was sufficient to reduce levels of apoptosis (Figure 4b ) and inhibit cytochrome c release (Figure 4c ) induced by hypoxic stress with DFX treatment whether or not Tid1 was over-expressed. Over-expression of Tid1 enhanced the intrinsic mitochondrial cell death pathway, (Schuler et al., 2000; Cui et al., 2007) (Figures 4a-c) which was not associated with changes in levels of PUMA (Figure 4d ), an important pro-apoptotic Bcl-2 family member and p53 target gene (Wang et al., 2007) . Although we cannot rule out that other mitochondria matrix proteins act as a vehicle for p53 translocation to mitochondria, these results suggest that ablation of the mitochondrial targeting sequence or mutation of the DnaJ domain of Tid1 restricted p53 to the cytosol and inhibited hypoxia stress-induced apoptosis in human breast cancer cells through the intrinsic mitochondrial cell death pathway, possibly through a p53-dependent manner.
Over-expression of Tid1 enhances p53-dependent apoptosis and restores the mitochondrial translocation and pro-apoptotic activity of mutant p53 To further assess whether Tid1 regulation of hypoxiainduced apoptosis is dependent on mitochondrial p53, the effects of Tid1 over-expression on the extent of hypoxia stress-induced apoptosis by DFX treatment were examined in cells lacking expression of p53. HCT116 colon carcinoma cells lacking p53 (p53 À/À ) or expressing wild-type p53 (p53 wt ) were infected with either Ad-Tid1 S or Ad-Scramble. As expected, endogenous p53 in HCT116 p53 À/À cells was undetectable before and after DFX treatment, whereas the level of p53 in HCT116 p53 wt cells increased significantly after DFX treatment (Figure 5a ). Ad-Scramble-or Ad-Tid1 Sinfected HCT116 p53 wt cells showed apoptosis after DFX treatment, whereas little or no apoptosis was observed in similarly infected HCT116 p53 À/À cells (Figure 5b ). To examine if complementation of p53 can restore the apoptotic response to DFX treatment in Ad-Tid1s-infected HCT116 p53
À/À cells, we co-infected HCT116 p53
À/À cells with Ad-Tid1 S and Ad-p53 wt or Ad-p53 mtÀ175H , a mutant form of p53 defective in transcriptional and apoptotic function (Hinds et al., 1990; Wang et al., 1998) . As shown in Figure 5c , in untreated cells in the absence of Tid1 over-expression, little to no apoptosis was observed in HCT116 p53 À/À cells infected with Ad-p53 mtÀ175H , whereas the cells infected with Ad-p53 wt showed a slightly higher degree of apoptosis when compared with Ad-Scramble-infected control p53 subcellular localization and apoptosis BY Ahn et al cells. Once Tid1 is also over-expressed, however, the amount of apoptosis observed in untreated cells infected with Ad-p53 mtÀ175H increased to levels similar to that observed in cells expressing wild-type p53. Subcellular fractionation experiments showed that a greater amount of p53 was also detected in the mitochondrial The purity of each cell fraction was monitored by immunoblotting analysis for cytoplasmic (b-tubulin) and mitochondrial (mtHsp70) markers. To compare protein expression levels within each cell fraction, the same volume (20 ml) of fractionated cell lysates was loaded in each well. Subcelluar fractions were further analysed by immunoprecipitation using 2 mg of anti-p53, anti-Tid1 or control IgG antibody (*) and analysed by immunoblotting for p53 and Tid1 (lower). (c) Cells labeled with Mitotracker (blue), for mitochondrial staining, and anti-p53 antibody (red), were visualized by confocal microscopy. White boxes in merged images of third column indicate insets enlarged in merged images of fourth column. (d) TdT-mediated dUTP nick end labeling (TUNEL) assays were performed as described in Figure 1a. p53 subcellular localization and apoptosis BY Ahn et al fractions in cells that also over-expressed Tid1 (Figure 5d ), which was also confirmed by immunofluorescence co-localization of p53 and Tid1 (Supplementary Figure S9 ). This suggests that Tid1 over-expression leads to enhanced levels of apoptosis in cells coexpressing either wild-type or mutant forms of p53 even in the absence of hypoxic stress, confirming that p53 transcriptional activity is not required for apoptosis. These experiments also eliminate the possibility that Tid1 is a tumor suppressor protein, and may also exert its tumor suppressor activity by functioning as a cell death regulator (Edwards and Munger 2004; Kim et al., 2004 Kim et al., , 2005 .
Over-expression of Tid1 in cancer cell lines restores the pro-apoptotic ability of p53 mutants Mutations in p53 often result in aberrant localization of the mutant p53 proteins and loss of their transcriptional and pro-apoptotic activity Chipuk and Green, 2008) , a significant therapeutic problem in cancer ) that expressed either wild-type or mutant p53. In cell lines expressing wild-type p53, DFX treatment was required to stabilize p53 protein levels, although, as observed earlier, DFX treatment did not affect Tid1 protein levels ( Figure 6a ). As expected, cell lines with mutant p53 expressed high levels of p53 protein, and neither p53 nor Tid1 protein levels were affected by treatment with DFX (upper); however, Tid1 protein levels in the mutant p53 cell lines were noticeably and consistently lower than the protein levels of Tid1 observed in the cell lines with wildtype p53 (middle). After DFX treatment, p53 predominantly localized to the nucleus in the mutant p53 cell lines, whereas it was mostly localized to the mitochondria in the wild-type p53 cell lines (Figure 6b) . The mutant p53 cell lines also showed a significantly lower percentage of apoptotic cells compared with that observed in the wild-type p53 cell lines in response to DFX treatment (Figure 6c) . Thus, lower levels of Tid1 in mutant p53-expressing cell lines correlated well with p53 nuclear localization and reduced levels of apoptosis. Therefore, we hypothesized that Tid1 over-expressing cancer cell lines with mutant p53 might promote mitochondrial localization of the mutant p53 protein, and thus enhance or restore their pro-apoptotic function. Each cell line was infected with Ad-scramble or ). Control cells were mock infected, or infected with Ad-Scramble. Forty-eight hours after infection, cells were treated with DFX (125 mM) for 6 h. (c) TUNEL assays were performed as described in Figure 1a . (d) Subcellular fractionation and immunoblotting were performed as described in Figure 1e . ) and mutant p53 (U373 p53R273H , T47D p53L194F , SK-BR-3 p53R175H and BT474 p53E285K ) were treated with desferroxamine (DFX) (125 mM) for 6 h in (a-c). In (d-f), breast cancer and glioma cell lines with wild-type p53 (MCF-7 p53wt , U87 p53wt ) and mutant p53 (U373 p53R273H , T47D p53L194F , SK-BR-3 p53R175H and BT474 p53E285K ) were infected with adenoviral constructs to overexpress Tid1 (Ad-Tid S ). Control cells were mock infected, or infected with Ad-Scramble. Forty-eight hours after infection, cells were treated with DFX (125 mM) for 6 h. Ad-Tid1 S showing that over-expression of Tid1 had no effect on p53 levels in any of the cell lines examined (Figure 6d , upper) but did enhance mitochondrial translocation of both wild type and mutant p53 (Figure 6e ). In addition, Tid1 over-expression increased apoptosis levels in cells expressing mutant p53 even in the absence of DFX treatment (Figures 5 and 6 ). Taken together, these results suggest that Tid1 over-expression can restore the pro-apoptotic activity of mutant p53 proteins in human breast cancer and glioma cells, by enhancing mitochondrial translocation of mutant p53 protein.
Discussion p53 mediates its cellular functions through its ability to regulate the transcription of multiple target genes, including many that promote either cell cycle arrest or apoptosis. (Vogelstein et al., 2000) In addition, p53 has been shown to induce a transcription-independent apoptosis pathway in mitochondria (Mihara et al., 2003; Murphy et al., 2004) . Despite the known importance of subcellular location in p53 function, the mechanism(s) regulating the subcellular trafficking of p53 and, in particular, its translocation to the mitochondria was not understood. Some have suggested that Bcl-2 family members may interact with p53 to facilitate its translocation from the cytosol to the mitochondria, as p53 is known to form complexes with Bcl-x L , Bak or Bax at the mitochondria (Mihara et al., 2003; Chipuk et al., 2004; Leu et al., 2004; Perfettini et al., 2004) . However, Bcl-2 is mostly localized within the mitochondria and the endoplasmic reticulum (Chipuk and Green, 2008) , and others have recently shown that the Bcl-2 family members PUMA and BAX are not involved in mitochondrial trafficking of p53 . Although we cannot rule out the possibility that other Bcl-2 family members or other mitochondrial matrix proteins are involved in the regulation of p53's mitochondrial translocation in response to cellular stress, our data emphasize that Tid1 is a key regulatory factor of p53's subcellular localization and apoptosis through the intrinsic mitochondrial pathway.
There are several possible mechanisms through which Tid1 could regulate p53 translocation to the mitochondria in response to hypoxic conditions. One possibility is that Tid1 may be involved in the switch between Bcl-2 and Bax in the formation of p53 complexes in the mitochondria. Other possibilities are that Tid1 may be involved in p53 modifications under stress conditions. Phosphorylation/acetylation modifications of p53 are not involved in mitochondrial targeting and p53 itself lacks a mitochondrial translocation motif (Nemajerova et al., 2005) , but its monoubiquitylation by MDM2 promotes its mitochondrial translocation under stress conditions (Marchenko et al., 2007) . Nonetheless, p53 does not require MDM2 as a 'shuttler' (Marchenko et al., 2007) . We have shown earlier that Tid1 is involved in the ubiquitylation of HER2; therefore, it is possible that Tid1 could also be involved in p53 ubiquitylation, possibly by regulating MDM2 or other ubiquitin ligases.
Many tumors contain p53 mutations, but whether or not tumor cells harboring mutant p53 have an impaired p53-mediated apoptosis pathway remains controversial. For example, Moll's group have shown that p53 mutants that have mutations within the DNA-binding domain could not form complexes with endogenous Bcl-2 in human cancer cells and failed to undergo apoptosis (Mihara et al., 2003) . In contrast, others have found that cells harboring the R273H or the Gln22, Ser23 p53 mutants can still undergo apoptosis (Bissonnette et al., 1997; Kokontis et al., 2001) . It is also possible that mutant p53 can mediate apoptosis at the mitochondria through additional Bcl-2-independent mechanisms; in this regard, mutant p53 has also been shown to bind directly with Bax or Bak in response to cellular stress (Chipuk et al., 2004; Leu et al., 2004; Perfettini et al., 2004) . Moreover, p53 DNA-binding domain mutants R273H and C277F can still induce the oligomerization of Bak in vitro (Pietsch et al., 2008) . Although Moll's group reported that mitochondrial p53 can induce apoptosis after genotoxic stress independent of Bax or PUMA and others have shown that Bak is the target of p53, our studies found that Bax inhibition blocks cytochrome c release after hypoxic stress (Figure 4c ).
Our studies provide evidence that cancer cells expressing several different p53 mutants have an intact mitochondrial p53-mediated apoptotic pathway, yet the failure of mutant p53 to translocate to mitochondria often prevents apoptosis from occurring. Restoring the ability of mutant p53 to mitochondria with high levels of Tid1 restores the pro-apoptotic function of many mutant p53 proteins.
Overall, our findings have clinical relevance, as they suggest that cancer therapeutics designed to increase Tid1 expression levels or enhance Tid1's function in cancer cells may be a novel means of promoting apoptosis in tumors that express either wild-type or mutant forms of p53.
Materials and methods

Cells, plasmids and virus
The human breast cancer cell lines, MCF-7, T47D, SK-BR-3, BT474, and the human glioma cell lines, U87, U373, were grown in Dulbecco's modified Eagle medium supplemented with 10% fetal bovine serum. The human colon carcinoma cell lines HCT116 (expressing wild-type p53) and HCT116 (p53 À/À ), were kindly provided by Dr Karl Riabowol (University of Calgary, Calgary, AB, Canada) and were maintained in McCoy's 5A medium supplemented with 10% fetal bovine serum.
Full-length complementary DNAs encoding human Tid1 S , Tid1 L , anda Tid1-specific sequence containing a hairpin loop (5 0 -GATCCCCAGCTACGGCTACGGAGACTTCAAGAG AGTCTCCGTAGCCGTAGCTGTTTTTGGAAA-3 0 ) were cloned into the pAdTrack-cytomegalovirus adenovirus shuttle vector (Q-Biogene, Solon, OH, USA). Adenoviruses p53 subcellular localization and apoptosis BY Ahn et al expressing p53 wt or p53 mtÀ175F were kindly provided by Dr Riabowol.
Breast cancer cell lines in 10 cm plates (1 Â 10 6 cells/plate) were infected with adenoviruses containing the various constructs for 6 h.
Stresses and reagents
Cells were incubated in medium containing 125 mM desferroxamine mesylate (DFX, Sigma, St Louis, MO, USA) for the time periods indicated. BAX-inhibitor peptide, caspase-9 inhibitor, Z-Lue-Gln(OMe)-His-Asp(OMe)-fluoromethylketone (Z-LEHD-FMK) and caspase-8 inhibitor, Z-Ile-Glu (OMe)-Thr-Asp(OMe)-fluoromethylketone (Z-IETD-FMK), and a corresponding negative control peptide (Calbiochem, Gibbstown, NJ, USA) were diluted in culture medium to a final concentration of 20 mM and cells treated for the time periods indicated.
Subcellular fractionation, immunoprecipitation and immunoblotting
Cells were lysed with RIPA buffer (20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.5% (v/v) NP-40, protease inhibitor cocktail (Roche, Indianapolis, IN, USA). Nuclear, cytoplasmic and mitochondrial fractions were prepared using a Qproteome mitochondria extraction kit and a Qproteome nucleus extraction kit (Qiagen) according to the manufacturer's protocol.
Immunoprecipitation was performed by incubating whole cell lysates or individual fractions with the indicated antibody in the presence of Protein A/G Plus agarose beads (Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 2 h.
Immunoblots were probed with anti-p53 (FL-393 or DO-1), anti-Tid1 (RS-11), anti-actin (C-11), anti-PARP 1/2 (H-250), anti-PUMAa (N-19), anti-cytochrome c (C-20) antibodies, anti-lamin A (H-102), or anti-b-tubulin (H-235) (Santa Cruz Biotechnology) and anti-mtHsp70 (Transduction Labs, Oxford, UK) antibodies.
Confocal microscopy
Cells grown in the 16-well Lab-Tek chamber slide system (Nalgene Nunc, Rochester, NY, USA) were stained with 100 nM Mitotracker Green-FM or Mitotracker Deep Red-FM (Invitrogen, Carlsbad, CA, USA) at 37 1C for 30 min and then fixed in 4% paraformaldehyde at room temperature for 10 min. Fixed cells were blocked with 3% (w/v) bovine serum albumin in phosphate-buffered saline and stained with antip53 (FL-393) polyclonal and anti-Tid1 (RS11) antibodies in combination with Alexa Fluor-568 anti-rabbit or mouse, Alexa Fluor-488 anti-mouse, or Alexa Fluor-633 anti-rabbit or mouse antibodies (Invitrogen, Carlsbad, CA, USA). Nuclei were stained with TO-PRO iodide (Invitrogen). Stained cells were examined using a Zeiss LSM 510 Laser Scanning Confocal Microscope (Carl Zeiss Canada, Toronto, ON, Canada).
Cell viability assay
The WST-1 assay was performed according to the manufacturer's protocol (Roche Diagnostics) on confluent cells cultured in 96-well plates. Cell viability of breast cancer MCF-7 cells cultured in the presence of studied drugs was calculated as a percentage of control untreated cells.
Apoptosis assays
Apoptotic cells were detected by TdT-mediated dUTP nick end labeling assays using the In Situ Cell Death Detection Kit AP (Roche Diagnostics) on cells grown in 16-well Lab-Tek chamber slides according to the manufacturer's protocol, and quantitated by counting the number of TdT-mediated dUTP nick end labeling-positive relative to TdT-mediated dUTP nick end labeling-negative cells. A minimum of 100 cells were counted for four different fields and results were presented as the percentage of total cells undergoing apoptosis.
Cell cycle analysis
Cell cycle status was assessed by the sub-G 1 , G1 þ G2 fraction of propidium iodide-labeled cells (2 mg/ml, Sigma) on a FACScan (Becton Dickinson, San Jose, CA, USA) (10 000 events each).
